19 December 2014 - Press Releases
Karus Therapeutics presenting at Biotech Showcase 2015
Dr Simon Kerry, CEO of Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, will be attending and presenting at Biotech Showcase 2015, 12-14 January 2015 in San Francisco.
2-5 Nov 2014
NCRI, Liverpool, UK
21 October 2014 - Press Releases
Karus Therapeutics Appoints New Head of Clinical Development and Head of Biology
Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory diseases and cancer, today announced that it has further strengthened its R&D team with two new appointments; Dr Simon Roitt, who joins as Head of Clinical Development and Dr Peter Finan, who has been appointed as Karus’s Head of Biology.
7 Oct 2014
UK Bioscience Forum, London, UK
30 Sep-01 Oct 2014
SACHS Biotech in Europe Forum, Basel, Switzerland
29 September 2014 - Press Releases
Karus Therapeutics presenting at NCRI Cancer Conference
Stephen Shuttleworth, CSO of Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, will be attending and presenting two posters at the 10th NCRI Cancer Conference, 2-5 November 2014 in Liverpool.
08 September 2014 - Press Releases
Karus Therapeutics presenting at SACHS Biotech in Europe Forum
Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, has announced that Simon Kerry, CEO, will be presenting at the SACHS Biotech in Europe Forum, 30 September – 01 October, 2014 in Basel, Switzerland.
19 June 2014
European MediScience Awards Dinner, London, UK
15 May 2014 - In the News
Karus Therapeutics features in SciBX
Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, was featured in the cover story of SciBX, ‘Chromatin’s rising tide’.
12-14 May 2014
BioTrinity 2014, London, UK
5-9 April 2014
AACR, San Diego, USA
03 April 2014 - Press Releases
Karus Therapeutics presenting at AACR Annual Meeting 2014
Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, has announced that it will be giving two poster presentations at the AACR Annual Meeting in San Diego, 5-9th April 2014.
25 February 2014 - In the News
Karus Therapeutics showcased in BVCA’s Britain’s Hot Talents 2014/15
Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, has been featured in the British Private Equity and Venture Capital Association (BVCA)’s handbook of venture capital innovation, Britain’s Hot Talent.
13-16 Jan 2014
Biotech Showcase and J.P. Morgan 32nd Annual Healthcare Conference, San Francisco, USA
Karus Therapeutics Limited
Genesis Building
Library Avenue
Harwell Campus
Oxfordshire OX11 0SG
Tel + 44 (0)1235 829140
Fax + 44 (0)1235 420517
E info@karustherapeutics.com
Registered in England & Wales No 05490954
VAT No 871 4126 33
© 2017 Karus Therapeutics
All Rights Reserved.
